Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Vertex Pharmaceuticals Inc

NASDAQ: VRTX · Life Sciences · 5 alerts · CIK 875320

Share price
$537.79Close, Nov 16
Market cap
$136B
Shares outstanding
253.54MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Vertex Pharmaceuticals Inc filings on SEC EDGAR ↗

4:37 PM ET Form 4
Insider Selling

Vertex Pharmaceuticals EVP, Co & Fo Charles F. Wagner Jr. Sells $8.37M of Stock

Charles F. Wagner Jr., EVP, Co & Fo, sold 15,286 shares of Vertex Pharmaceuticals Inc at $547.87 a share, worth $8.37M in total on Nov 12, 2026. Shares held after the trade: 31,764 (-32.5%).

Value
$8.37M
Shares
15,286
Price
$547.87
Role
EVP, Co & Fo
Holding change
-32.5%
Trade date
Nov 12, 2026
4:21 PM ET Form 4
Insider Selling

Vertex Pharmaceuticals CEO & President Reshma Kewalramani Sells $6.31M of Stock

Reshma Kewalramani, CEO & President, sold 11,866 shares of Vertex Pharmaceuticals Inc at $531.53 a share, worth $6.31M in total on Nov 6, 2026. Shares held after the trade: 86,471 (-12.1%).

Value
$6.31M
Shares
11,866
Price
$531.53
Role
CEO & President
Holding change
-12.1%
Trade date
Nov 6, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.